Description
Clinical Description
Juvederm Skinvive (2 x 1ml) is a hyaluronic acid–based injectable skin booster developed for intradermal aesthetic treatment aimed at improving skin hydration, smoothness, and overall skin quality. Manufactured within the Juvederm range, the product uses cross-linked hyaluronic acid technology designed to retain moisture within the dermal tissue while supporting skin revitalisation and texture enhancement.
Unlike traditional volumising dermal fillers, juvederm skinvive skin booster is intended primarily for skin quality improvement rather than structural contour correction. The formulation incorporates lidocaine to support patient comfort during treatment procedures. Publicly available information describes the product as suitable for professional aesthetic use in areas demonstrating reduced hydration, diminished elasticity, or early signs of cutaneous ageing.
Juvederm Skinvive is supplied in sterile prefilled syringes and is intended for administration exclusively by qualified healthcare professionals trained in injectable aesthetic procedures under aseptic conditions.
What Juvederm Skinvive Is Similar To
Juvederm Skinvive belongs to the category of injectable skin boosters and is frequently compared with products such as Profhilo and Sunekos.
Like Profhilo, Juvederm Skinvive focuses primarily on hydration and skin quality enhancement through hyaluronic acid technology rather than deep volumisation. However, Profhilo uses high- and low-molecular-weight hyaluronic acid complexes intended for bio-remodelling, whereas Juvederm Skinvive uses cross-linked HA technology associated with longer dermal hydration retention.
Compared with Sunekos, which combines amino acids with non-cross-linked hyaluronic acid to support extracellular matrix activity, Juvederm Skinvive remains more focused on hydration and superficial dermal smoothness.
Longevity profiles and treatment protocols may differ between products depending on HA structure, injection depth, patient metabolism, and practitioner technique.
This comparison is provided for clinical orientation only and does not imply interchangeability.
Treatment Areas / Indications
According to publicly accessible manufacturer and distributor information, Juvederm Skinvive may be used for:
- Facial skin hydration
- Cheek skin quality improvement
- Skin smoothness enhancement
- Fine superficial textural irregularities
- General facial revitalisation
Additional treatment areas were not clearly specified in publicly available manufacturer documentation.
Usage / Administration (IFU-only Section)
Juvederm Skinvive is intended for administration exclusively by qualified medical professionals experienced in aesthetic injectable procedures and aseptic technique.
Injection depth:
Intradermal injection.
Volume per injection point:
Not provided by manufacturer in publicly accessible documentation.
Recommended needle gauge:
Not provided by manufacturer in publicly accessible documentation.
Frequency / number of sessions:
Not provided by manufacturer in publicly accessible documentation.
Professional-use statement:
The product should only be administered by trained healthcare practitioners with knowledge of facial anatomy, injection technique, and management of injection-related complications.
Some practitioners apply microdroplet or hydration-grid injection patterns with juvederm skinvive skin booster treatments; however, these methods are not included in the manufacturer’s official IFU guidance.
Ingredient List
- Cross-linked hyaluronic acid (HA)
- Lidocaine hydrochloride
- Phosphate buffer
- Sterile physiological solution
HA concentration: not provided by manufacturer.
Contains lidocaine: Yes.
Lidocaine concentration: not provided by manufacturer.
Presentation & Longevity
Juvederm Skinvive is supplied as:
- 2 × 1 mL prefilled syringes
The device is supplied sterile and intended for single-patient professional use.
Longevity / duration:
The duration of aesthetic effect may vary depending on patient metabolism, lifestyle, injection technique, and treatment area. Publicly available manufacturer information describes sustained hydration and skin-quality improvement effects; however, a definitive duration range was not consistently specified in publicly accessible IFU materials.
Shelf life:
Not provided by manufacturer in publicly accessible documentation.
Healthcare professionals evaluating Juvederm Skinvive price should verify packaging, batch information, and storage requirements directly from authorised distributors and manufacturer documentation.
Safety Notes / Contraindications
Juvederm Skinvive should not be used in patients with:
- Known hypersensitivity to hyaluronic acid, lidocaine, or formulation components
- Active infection, inflammation, or skin disease at the intended injection site
- History of severe allergic reactions or anaphylaxis
- Conditions that may increase the risk of injection-related complications
Potential adverse events associated with injectable HA products may include erythema, oedema, tenderness, bruising, papules, nodules, or delayed inflammatory responses.
The product should only be used by appropriately trained medical professionals familiar with injectable safety protocols and complication management.
Regulatory Status
- CE-marked injectable medical aesthetic device according to publicly available distributor documentation
- Intended for professional medical-aesthetic use
- Regulatory classification should be confirmed directly through manufacturer IFU documentation or regional regulatory databases
Additional regulatory verification may be performed through MHRA, EUDAMED, or local competent authorities where applicable.
FAQ
1. What is Juvederm Skinvive used for?
Juvederm Skinvive is used for intradermal skin-quality treatments focused on improving hydration, smoothness, and overall skin appearance. Unlike traditional volumising fillers, the product is designed primarily to enhance superficial skin quality rather than restore deep structural volume. It may be incorporated into facial rejuvenation protocols targeting dehydration, textural irregularities, and early visible signs of skin ageing.
2. Is Juvederm Skinvive a dermal filler or a skin booster?
Juvederm Skinvive is generally categorised as a skin booster rather than a traditional volumising dermal filler. Although it contains stabilised hyaluronic acid similar to filler products, its primary clinical purpose is dermal hydration and skin texture improvement. The treatment focus is therefore more closely associated with skin revitalisation than contour augmentation or structural volumisation.
3. Does Juvederm Skinvive contain lidocaine?
Yes. Juvederm Skinvive contains lidocaine hydrochloride to help improve patient comfort during injection procedures. Lidocaine is commonly incorporated into injectable hyaluronic acid products to reduce treatment discomfort. The exact lidocaine concentration was not clearly specified in the publicly accessible documentation reviewed for this description.
4. How long do Juvederm Skinvive results last?
Treatment longevity depends on multiple variables, including patient metabolism, treatment area, injection technique, and lifestyle factors. Publicly available information indicates that Juvederm Skinvive is intended to provide prolonged skin hydration and smoothness improvements, although a precise duration range was not consistently stated in accessible IFU documentation. Maintenance schedules are typically determined individually by the treating practitioner.
5. How does Juvederm Skinvive compare with Profhilo?
Both Juvederm Skinvive and Profhilo are injectable treatments focused on skin quality enhancement and hydration. However, their hyaluronic acid technologies differ. Profhilo uses thermally stabilised hybrid HA complexes, while Juvederm Skinvive uses cross-linked HA technology associated with dermal hydration retention. Product selection depends on practitioner preference, patient anatomy, treatment objectives, and desired aesthetic outcomes.
